Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04063475Unknown
Open-label, single-arm trial of N-butyl-2-cyanoacrylate in soft tissue atrophy, sponsored by Cairo University. Primary endpoint: Graft shrinkage at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04063475.